2024-03-28T12:50:35Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_543A8F0BDA2E
2024-03-23T02:23:06Z
serval:BIB_543A8F0BDA2E
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
10.1215/S1152851704000687
000228228000009
15831237
Wasserfallen
J.B.
author
Ostermann
S.
author
Leyvraz
S.
author
Stupp
R.
author
article
2005-04
Neuro-Oncology
1522-8517
journal
7
2
189-195
Adult
Aged
Antineoplastic Agents, Alkylating/economics
Antineoplastic Agents, Alkylating/therapeutic use
Brain Neoplasms/drug therapy
Brain Neoplasms/economics
Cost of Illness
Cost-Benefit Analysis
Dacarbazine/analogs &
derivatives
Dacarbazine/economics
Female
Glioma/drug therapy
Glioma/economics
Humans
Male
Middle Aged
Neoplasm Recurrence, Local/drug therapy
Neoplasm Recurrence, Local/economics
Survival Analysis
eng
60_published
true
peer-reviewed
Publication types: Clinical Trial ; Journal Article